Avantor, Inc. (AVTR)
| Market Cap | 11.78B |
| Revenue (ttm) | 6.78B |
| Net Income (ttm) | 711.50M |
| Shares Out | 680.90M |
| EPS (ttm) | 1.04 |
| PE Ratio | 16.63 |
| Forward PE | 16.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,547,897 |
| Open | 17.40 |
| Previous Close | 17.49 |
| Day's Range | 17.22 - 17.63 |
| 52-Week Range | 17.14 - 28.00 |
| Beta | 1.28 |
| Analysts | Buy |
| Price Target | 26.36 (+52.37%) |
| Earnings Date | Feb 7, 2025 |
About AVTR
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an... [Read more]
Financial Performance
In 2024, Avantor's revenue was $6.78 billion, a decrease of -2.64% compared to the previous year's $6.97 billion. Earnings were $711.50 million, an increase of 121.58%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $26.36, which is an increase of 52.37% from the latest price.
News
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference
RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE:...
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent...
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.
Avantor® Reports Fourth Quarter and Full Year 2024 Results
Fourth Quarter 2024 Net sales of $1.69 billion, decrease of 2%; organic growth of 1% Net income of $500.4 million; Adjusted EBITDA of $307.7 million Diluted GAAP EPS of $0.73; adjusted EPS of $0.27 Op...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, I...
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
RADNOR, Pa. , Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
RADNOR, Pa. , Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology ind...
Avantor: Durable FCF Generator Trading For Cheap
Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansi...
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (N...
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology ind...
Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent ...
Avantor® Reports Third Quarter 2024 Results
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flo...
Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23...
Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with t...
Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...
Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global p...
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
RADNOR, Pa. , Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology i...
Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement
Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues...
Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition
RADNOR, Pa. , Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology i...
Broyhill's Q2 2024 Top Five Investments
Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July a...
Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance
EcoVadis Rating validates Avantor's business sustainability commitments and performance RADNOR, Pa. , Sept. 12, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-cr...
Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
RADNOR, Pa. , Aug. 22, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in...